In this issue:
KRAS status predicts anti-EGFR response in metastatic CRC
Delaying colorectal cancer adjuvant chemo-therapy impacts survival
Blood-based gene expression profiles detect manifest NSCLC
Adding vatalanib to chemo-therapy in metastatic CRC
SALUTE: adding beva
Please login below to download this issue (PDF)